Human S-adenosylhomocysteine hydrolase

Common gene sequence variation and functional genomic characterization

Qiping Feng, Mani Keshtgarpour, Linda L. Pelleymounter, Irene Moon, Krishna R Kalari, Bruce W. Eckloff, Eric D Wieben, Richard M Weinshilboum

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

S-Adenosylhomocysteine hydrolase (AHCY) is the only mammalian enzyme known to catalyze the hydrolysis of S-adenosylhomocysteine. We have used a genotype-to-phenotype strategy to study this important enzyme by resequencing AHCY in 240 DNA samples from four ethnic groups. Thirty-nine polymorphisms were identified - 28 of which were novel. Functional genomic studies for wild type AHCY and the three variant allozymes identified showed that two variant allozymes had slight, but significant decreases in enzyme activity, but with no significant differences in levels of immunoreactive protein. Luciferase reporter gene assays for common 5′-flanking region haplotypes revealed that one haplotype with a frequency of ∼2% in Caucasian-American subjects displayed a decreased ability to drive transcription. The variant nucleotide at 5′-flanking region single nucleotide polymorphism (SNP) (-34) in that haplotype altered the DNA-protein binding pattern during electrophoresis mobility shift assay. Finally, an AHCY genotype-phenotype association study for expression in lymphoblastoid cells identified four SNPs that were associated with decreased expression. For the IVS6 (intervening sequence 6, i.e., intron 6) G56 > C SNP among those four, electrophoresis mobility shift assay showed that a C > G nucleotide change resulted in an additional shifted band. These results represent a step toward understanding the functional consequences of common genetic variation in AHCY for the regulation of neurotransmitter, drug and macromolecule methylation.

Original languageEnglish (US)
Pages (from-to)1806-1817
Number of pages12
JournalJournal of Neurochemistry
Volume110
Issue number6
DOIs
StatePublished - Sep 2009

Fingerprint

Adenosylhomocysteinase
Haplotypes
Single Nucleotide Polymorphism
Nucleotides
Genes
5' Flanking Region
Polymorphism
Electrophoretic Mobility Shift Assay
Assays
Introns
Isoenzymes
Electrophoresis
Enzymes
S-Adenosylhomocysteine
Drug and Narcotic Control
DNA-Binding Proteins
Genetic Association Studies
Luciferases
Reporter Genes
Ethnic Groups

Keywords

  • AHCY
  • Functional genomics
  • Gene resequencing
  • Gene sequence variation
  • S-adenosylhomocysteine hydrolase
  • Single nucleotide polymorphisms

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Human S-adenosylhomocysteine hydrolase : Common gene sequence variation and functional genomic characterization. / Feng, Qiping; Keshtgarpour, Mani; Pelleymounter, Linda L.; Moon, Irene; Kalari, Krishna R; Eckloff, Bruce W.; Wieben, Eric D; Weinshilboum, Richard M.

In: Journal of Neurochemistry, Vol. 110, No. 6, 09.2009, p. 1806-1817.

Research output: Contribution to journalArticle

Feng, Qiping ; Keshtgarpour, Mani ; Pelleymounter, Linda L. ; Moon, Irene ; Kalari, Krishna R ; Eckloff, Bruce W. ; Wieben, Eric D ; Weinshilboum, Richard M. / Human S-adenosylhomocysteine hydrolase : Common gene sequence variation and functional genomic characterization. In: Journal of Neurochemistry. 2009 ; Vol. 110, No. 6. pp. 1806-1817.
@article{e138615e52ee424f9be912642a7091f7,
title = "Human S-adenosylhomocysteine hydrolase: Common gene sequence variation and functional genomic characterization",
abstract = "S-Adenosylhomocysteine hydrolase (AHCY) is the only mammalian enzyme known to catalyze the hydrolysis of S-adenosylhomocysteine. We have used a genotype-to-phenotype strategy to study this important enzyme by resequencing AHCY in 240 DNA samples from four ethnic groups. Thirty-nine polymorphisms were identified - 28 of which were novel. Functional genomic studies for wild type AHCY and the three variant allozymes identified showed that two variant allozymes had slight, but significant decreases in enzyme activity, but with no significant differences in levels of immunoreactive protein. Luciferase reporter gene assays for common 5′-flanking region haplotypes revealed that one haplotype with a frequency of ∼2{\%} in Caucasian-American subjects displayed a decreased ability to drive transcription. The variant nucleotide at 5′-flanking region single nucleotide polymorphism (SNP) (-34) in that haplotype altered the DNA-protein binding pattern during electrophoresis mobility shift assay. Finally, an AHCY genotype-phenotype association study for expression in lymphoblastoid cells identified four SNPs that were associated with decreased expression. For the IVS6 (intervening sequence 6, i.e., intron 6) G56 > C SNP among those four, electrophoresis mobility shift assay showed that a C > G nucleotide change resulted in an additional shifted band. These results represent a step toward understanding the functional consequences of common genetic variation in AHCY for the regulation of neurotransmitter, drug and macromolecule methylation.",
keywords = "AHCY, Functional genomics, Gene resequencing, Gene sequence variation, S-adenosylhomocysteine hydrolase, Single nucleotide polymorphisms",
author = "Qiping Feng and Mani Keshtgarpour and Pelleymounter, {Linda L.} and Irene Moon and Kalari, {Krishna R} and Eckloff, {Bruce W.} and Wieben, {Eric D} and Weinshilboum, {Richard M}",
year = "2009",
month = "9",
doi = "10.1111/j.1471-4159.2009.06276.x",
language = "English (US)",
volume = "110",
pages = "1806--1817",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Human S-adenosylhomocysteine hydrolase

T2 - Common gene sequence variation and functional genomic characterization

AU - Feng, Qiping

AU - Keshtgarpour, Mani

AU - Pelleymounter, Linda L.

AU - Moon, Irene

AU - Kalari, Krishna R

AU - Eckloff, Bruce W.

AU - Wieben, Eric D

AU - Weinshilboum, Richard M

PY - 2009/9

Y1 - 2009/9

N2 - S-Adenosylhomocysteine hydrolase (AHCY) is the only mammalian enzyme known to catalyze the hydrolysis of S-adenosylhomocysteine. We have used a genotype-to-phenotype strategy to study this important enzyme by resequencing AHCY in 240 DNA samples from four ethnic groups. Thirty-nine polymorphisms were identified - 28 of which were novel. Functional genomic studies for wild type AHCY and the three variant allozymes identified showed that two variant allozymes had slight, but significant decreases in enzyme activity, but with no significant differences in levels of immunoreactive protein. Luciferase reporter gene assays for common 5′-flanking region haplotypes revealed that one haplotype with a frequency of ∼2% in Caucasian-American subjects displayed a decreased ability to drive transcription. The variant nucleotide at 5′-flanking region single nucleotide polymorphism (SNP) (-34) in that haplotype altered the DNA-protein binding pattern during electrophoresis mobility shift assay. Finally, an AHCY genotype-phenotype association study for expression in lymphoblastoid cells identified four SNPs that were associated with decreased expression. For the IVS6 (intervening sequence 6, i.e., intron 6) G56 > C SNP among those four, electrophoresis mobility shift assay showed that a C > G nucleotide change resulted in an additional shifted band. These results represent a step toward understanding the functional consequences of common genetic variation in AHCY for the regulation of neurotransmitter, drug and macromolecule methylation.

AB - S-Adenosylhomocysteine hydrolase (AHCY) is the only mammalian enzyme known to catalyze the hydrolysis of S-adenosylhomocysteine. We have used a genotype-to-phenotype strategy to study this important enzyme by resequencing AHCY in 240 DNA samples from four ethnic groups. Thirty-nine polymorphisms were identified - 28 of which were novel. Functional genomic studies for wild type AHCY and the three variant allozymes identified showed that two variant allozymes had slight, but significant decreases in enzyme activity, but with no significant differences in levels of immunoreactive protein. Luciferase reporter gene assays for common 5′-flanking region haplotypes revealed that one haplotype with a frequency of ∼2% in Caucasian-American subjects displayed a decreased ability to drive transcription. The variant nucleotide at 5′-flanking region single nucleotide polymorphism (SNP) (-34) in that haplotype altered the DNA-protein binding pattern during electrophoresis mobility shift assay. Finally, an AHCY genotype-phenotype association study for expression in lymphoblastoid cells identified four SNPs that were associated with decreased expression. For the IVS6 (intervening sequence 6, i.e., intron 6) G56 > C SNP among those four, electrophoresis mobility shift assay showed that a C > G nucleotide change resulted in an additional shifted band. These results represent a step toward understanding the functional consequences of common genetic variation in AHCY for the regulation of neurotransmitter, drug and macromolecule methylation.

KW - AHCY

KW - Functional genomics

KW - Gene resequencing

KW - Gene sequence variation

KW - S-adenosylhomocysteine hydrolase

KW - Single nucleotide polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=69949137188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69949137188&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2009.06276.x

DO - 10.1111/j.1471-4159.2009.06276.x

M3 - Article

VL - 110

SP - 1806

EP - 1817

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 6

ER -